Welcome to the next generation of cancer imaging and treatment.
Powerful Small Molecule Platform
Predictive Companion Diagnostic
Targeted Alpha Therapy
Who We Are
We’re on a mission to cure breast, ovarian and prostate cancer. Our team of experts and scientific board of advisors have extensive experience in small molecule radiopharmaceuticals and a proven track record in scientific research and multi-center trials. We are well positioned to hit the ground running with our unique theranostic solution. Trevarx offers multi-center trial expertise, regulatory support and GMP manufacturing to foster rapid commercialization of our radiopharmaceutical technologies.
Why Trevarx?
Our unique approach takes advantage of the proven PARPi platform to identify PARP-1 expressing tumors to guide PARPi therapy and to deliver powerful cancer treatment via small molecule radioisotopes. This allows for more precise identification, targeting and destruction of cancer at the sub-cellular level through lethal, double-stranded DNA breaks.
Partner With Us
Learn how you can be a part of the paradigm-changing solution that will change the way we treat cancer.
Partner With Us
Learn how you can be a part of the paradigm-changing solution that will change the way we treat cancer.